INTS (Intensity Therapeutics, Inc. Common stock) Stock Analysis - Community

Intensity Therapeutics, Inc. Common stock (INTS) is a publicly traded Healthcare sector company. As of May 21, 2026, INTS trades at $4.63 with a market cap of $12.38M and a P/E ratio of -0.54. INTS moved +0.87% today. Year to date, INTS is -53.23%; over the trailing twelve months it is -55.35%. Its 52-week range spans $4.50 to $100.00. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces INTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade INTS?

Rallies community data for INTS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

INTS Key Metrics

Key financial metrics for INTS
MetricValue
Price$4.63
Market Cap$12.38M
P/E Ratio-0.54
EPS$-8.56
Dividend Yield0.00%
52-Week High$100.00
52-Week Low$4.50
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-11.61M
Gross Margin0.00%

Latest INTS News

INTS Analyst Consensus

2 analysts cover INTS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.

Common questions about INTS

How does the Rallies community trade INTS?
Rallies community data for INTS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for INTS?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for INTS when enough community data is available.
Is INTS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INTS. It does not provide personalized investment advice.
INTS

INTS